NAMDIATREAM is a R&D project aiming at dramatically increase the sensitivity of cancer diagnostic methods enabling early detection and imaging of molecular biomarkers of the most common cancer types (lung, breast and prostate cancers), as well as permitting the identification of cells indicative of early-stage disease onset.
